Medera Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Rawat · Pakistan
Islamabad/Rawat pharmaceutical manufacturer established in the early 2000s with tablets, capsules, liquids, semisolids and injectable production.
Medera Pharmaceuticals products in Pakistan
Medera Pharmaceuticals (Pvt) Ltd has 89 medicine presentations registered in Pakistan under 59 brands, covering 47 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Olentine (Olanzapine + Fluoxetine), Avecare (Ceftriaxone), Azinal (Azithromycin) and Respimed (Risperidone). 89 products have an official DRAP price on MedInfoBase. See all 59 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Medera Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 2, Street N-4, National Industrial Zone, Rawat, Islamabad, Pakistan
- Website
- mederapk.com ↗
- Phone
- +92 51 4499190; +92 345 8555946
- medera@mederapk.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Medera Pharmaceuticals (Pvt) Ltd is priced against the market
85 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Avecare | Ceftriaxone | 500 mg | IM injection | 1's | 086143 | PKR 336.92 | PKR 336.92/vial/unit | 🔒 Pharma Pro |
| Avecare | Ceftriaxone | 500 mg | IV injection | 1's | 086144 | PKR 336.92 | PKR 336.92/vial/unit | 🔒 Pharma Pro |
| Avecare | Ceftriaxone | 1 g | Injection | 1's | 086145 | PKR 636.18 | PKR 636.18/vial/unit | 🔒 Pharma Pro |
| Avecare | Ceftriaxone | 250 mg | Injection | 1's | 087390 | PKR 196.09 | PKR 196.09/vial/unit | 🔒 Pharma Pro |
| Avecef | Cefixime | 400 mg | Capsule | 5's | 087391 | PKR 592.03 | PKR 118.41/capsule | 🔒 Pharma Pro |
| Avecef | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 087392 | PKR 330.39 | PKR 11.01/mL | 🔒 Pharma Pro |
| Avecef | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 087393 | PKR 404.33 | PKR 13.48/mL | 🔒 Pharma Pro |
| Azcin | Azithromycin | 500 mg | Tablet | 6's | 106145 | PKR 441.57 | PKR 73.60/tablet | 🔒 Pharma Pro |
| Azcin | Azithromycin | 250 mg | Tablet | 6's | 106146 | PKR 240.86 | PKR 40.14/tablet | 🔒 Pharma Pro |
| Azinal | Azithromycin | 500 mg | Capsule | 3's | 073020 | PKR 247.73 | PKR 82.58/capsule | 🔒 Pharma Pro |
| Azinal | Azithromycin | 200 mg/5 mL | Dry suspension | 30ml | 073021 | PKR 603.35 | PKR 20.11/mL | 🔒 Pharma Pro |
| Azinal | Azithromycin | 250 mg | Capsule | 6's | 116369 | PKR 305.19 | PKR 50.87/capsule | 🔒 Pharma Pro |
| Azinal | Azithromycin | 250 mg | Capsule | 10's | 116369 | PKR 508.64 | PKR 50.86/capsule | 🔒 Pharma Pro |
| B.M.T | Betamethasone | 0.1% | Lotion | 60ml | 072710 | PKR 156.65 | PKR 2.61/mL | 🔒 Pharma Pro |
| Cip-Era | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 072718 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Cip-Era 250 Dry Susp | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 072719 | PKR 198.19 | PKR 3.30/mL | 🔒 Pharma Pro |
| Cip-Era-250 | Ciprofloxacin | 250 mg | Tablet | 10’S | 072713 | PKR 257.65 | PKR 25.77/tablet | 🔒 Pharma Pro |
| Cip-Era-500 | Ciprofloxacin | 500 mg | Tablet | 10’S | 072714 | PKR 426.10 | PKR 42.61/tablet | 🔒 Pharma Pro |
| Clarimed 125 Dry Sus | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 073022 | PKR 441.96 | PKR 7.37/mL | 🔒 Pharma Pro |
| Climed | Clindamycin | 2% | Cream | 40gm | 072702 | PKR 568.80 | PKR 14.22/g | 🔒 Pharma Pro |
| Climed | Clindamycin | 1 % | Gel | 10gm | 111036 | PKR 172.58 | PKR 17.26/g | 🔒 Pharma Pro |
| Climed Plus | Clindamycin + Benzoyl peroxide | 1% + 5% | Gel | 10gm | 111037 | PKR 396.93 | PKR 39.69/g | No comparator |
| Climed-T | Clindamycin | 10 mg/mL | Lotion | 30ml | 115341 | PKR 216.16 | PKR 7.21/mL | 🔒 Pharma Pro |
| Clomicort H | Clotrimazole | 1 % | Cream | 10gm | 113780 | PKR 123.92 | PKR 12.39/g | 🔒 Pharma Pro |
| Clomipera | Clomipramine | 25 mg | Tablet | 20's | 112079 | PKR 276.12 | PKR 13.81/tablet | 🔒 Pharma Pro |
| Clomipera | Clomipramine | 75 mg | Tablet | 20's | 113173 | PKR 330.45 | PKR 16.52/tablet | 🔒 Pharma Pro |
| Clovimed | Aciclovir | 5 % | Cream | 10gm | 116351 | PKR 392.81 | PKR 39.28/g | 🔒 Pharma Pro |
| Co-Losium | Losartan + Hydrochlorothiazide | 50 mg + 12.5 mg | Tablet | 2X10's | 073014 | PKR 594.57 | PKR 29.73/tablet | 🔒 Pharma Pro |
| Diuton | Spironolactone | 100 mg | Tablet | 10's | 113162 | PKR 277.95 | PKR 27.80/tablet | 🔒 Pharma Pro |
| E-Dran | Amiodarone | 200 mg | Tablet | 30's | 099894 | PKR 388.30 | PKR 12.94/tablet | 🔒 Pharma Pro |
| Eravanco | Vancomycin | 1 g | Injection | 1's | 110991 | PKR 1,950.13 | PKR 1,950.13/vial/unit | 🔒 Pharma Pro |
| Eravanco | Vancomycin | 500 mg | Injection | 1's | 110992 | PKR 1,208.05 | PKR 1,208.05/vial/unit | 🔒 Pharma Pro |
| Es-Amazole 20 CapsulesRegistry verified | Esomeprazole (as magnesium trihydrate enteric coated pellets), Esomeprazole as magnesium eq. to Esomeprazole | — | — | — | 072721Official source ↗ | No indexed price | — | — |
| Es-Amazole 40 CapsulesRegistry verified | Esomeprazole (as magnesium trihydrate enteric coated pellets) | — | — | — | 072722Official source ↗ | No indexed price | — | — |
| Fantar-40 | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 075349 | PKR 523.21 | PKR 65.40/tablet | 🔒 Pharma Pro |
| Fantar-80 | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 6's | 075433 | PKR 654.03 | PKR 109.01/tablet | 🔒 Pharma Pro |
| Fluotine | Fluoxetine | 20 mg | Capsule | 10's | 119494 | PKR 134.24 | PKR 13.42/capsule | 🔒 Pharma Pro |
| Fosemed | Fosfomycin | 250 mg | Dry suspension | 60ml | 073025 | PKR 178.37 | PKR 2.97/mL | No comparator |
| Frusa | Furosemide | 40 mg | Tablet | 10x10's | 113161 | PKR 319.67 | PKR 3.20/tablet | 🔒 Pharma Pro |
| Fungimed | Fluconazole | 50 mg/5 mL | Dry suspension | 35ml | 073024 | PKR 416.20 | PKR 11.89/mL | 🔒 Pharma Pro |
| Levor-250 | Levofloxacin | 250 mg | Tablet | 10’S | 072711 | PKR 495.46 | PKR 49.55/tablet | 🔒 Pharma Pro |
| Levor-500 | Levofloxacin | 500 mg | Tablet | 10’S | 072712 | PKR 824.46 | PKR 82.45/tablet | 🔒 Pharma Pro |
| Linzid | Linezolid | 600 mg | Tablet | 12’S | 072715 | PKR 5,065.69 | PKR 422.14/tablet | 🔒 Pharma Pro |
| Linzid | Linezolid | 100 mg/5 mL | Suspension | 60ml | 072717 | PKR 693.66 | PKR 11.56/mL | 🔒 Pharma Pro |
| Linzid | Linezolid | 100 mg/5 mL | Suspension | 120ml | 072717 | PKR 1,317.96 | PKR 10.98/mL | 🔒 Pharma Pro |
| Losium | Losartan | 50 mg | Tablet | 20's | 075430 | PKR 396.37 | PKR 19.82/tablet | 🔒 Pharma Pro |
| Medchloro | Chloroquine | 250 mg | Tablet | 500's | 102283 | PKR 619.81 | PKR 1.24/tablet | 🔒 Pharma Pro |
| Medrofer | Iron polymaltose complex | 100 mg | Tablet | 20's | 115335 | PKR 355.13 | PKR 17.76/tablet | 🔒 Pharma Pro |
| Medrofer-F | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Chewable tablet | 30's | 115336 | PKR 458.19 | PKR 15.27/tablet | 🔒 Pharma Pro |
| Medropenum | Meropenem | 500 mg | IV injection | 1's | 113918 | PKR 2,209.88 | PKR 2,209.88/vial/unit | 🔒 Pharma Pro |
All 59 Medera Pharmaceuticals brands in Pakistan
- Avecare Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Avecef Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Azcin Azithromycin · 250 mg tablet, 500 mg tablet
- Azinal Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
- B.M.T Betamethasone · 0.1% lotion
- Cip-Era Ciprofloxacin · 125 mg/5 mL suspension
- Cip-Era 250 Dry Susp Ciprofloxacin · 250 mg/5 mL suspension
- Cip-Era-250 Ciprofloxacin · 250 mg tablet
- Cip-Era-500 Ciprofloxacin · 500 mg tablet
- Clarimed 125 Dry Sus Clarithromycin · 125 mg/5 mL suspension
- Climed Clindamycin · 1 % gel, 2% cream
- Climed Plus Clindamycin + Benzoyl peroxide · 1% + 5% gel
- Climed-T Clindamycin · 10 mg/mL lotion
- Clomicort H Clotrimazole · 1 % cream
- Clomipera Clomipramine · 25 mg tablet, 75 mg tablet
- Clovimed Aciclovir · 5 % cream
- Co-Losium Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- Diuton Spironolactone · 100 mg tablet
- E-Dran Amiodarone · 200 mg tablet
- Eravanco Vancomycin · 1 g injection, 500 mg injection
- Fantar-40 Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Fantar-80 Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Fluotine Fluoxetine · 20 mg capsule
- Fosemed Fosfomycin · 250 mg suspension
- Frusa Furosemide · 40 mg tablet
- Fungimed Fluconazole · 50 mg/5 mL suspension
- Levor-250 Levofloxacin · 250 mg tablet
- Levor-500 Levofloxacin · 500 mg tablet
- Linzid Linezolid · 100 mg/5 mL suspension, 600 mg tablet
- Losium Losartan · 50 mg tablet
- Medchloro Chloroquine · 250 mg tablet
- Medrofer Iron polymaltose complex · 100 mg tablet
- Medrofer-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- Medropenum Meropenem · 1 g injection, 500 mg injection
- Medvasc Amlodipine · 5 mg tablet
- Meloride Hydrochlorothiazide + Amiloride · 50 mg + 5 mg tablet
- Merospect Imipenem + Cilastatin · 500 mg + 500 mg injection
- Methrin Permethrin · 5% cream
- Mezicarb Carbamazepine · 200 mg tablet
- MiCool Oral Miconazole · 2 % gel
- MiCool-H Miconazole + Hydrocortisone · 2% + 1% cream
- Mosqonil Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- Moxider Moxifloxacin · 400 mg tablet
- Mudera Mupirocin · 2% cream
- N-Scab Permethrin · 5% lotion
- Olentine Olanzapine + Fluoxetine · 25 mg + 3 mg capsule, 25 mg + 6 mg capsule, 3 mg + 25 mg capsule
- Olentine 3/25 Olanzapine + Fluoxetine · 3 mg + 25 mg capsule
- Olentine 3/25mg Olanzapine + Fluoxetine · 3 mg + 25 mg capsule
- Olentine 6/25mg Olanzapine + Fluoxetine · 6 mg + 25 mg capsule
- Omicent Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Osteomed Cholecalciferol · 5 mg/mL injection
- Respimed Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Ritora 200/ Lopinavir + Ritonavir Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Tazonem Piperacillin + tazobactam · 2 g + 250 mg injection, 4 g + 0.5 g injection
- Terbimed Terbinafine · 1 % cream, 125 mg tablet, 250 mg tablet
- Viromed Entecavir · 0.5 mg tablet
- Vori-Era Dry Susp Voriconazole · 40 mg/mL suspension
- Zincera Zinc · 20 mg tablet
- Zolymed T Benzoyl peroxide · 5% cream
Medera Pharmaceuticals: common questions
How many products does Medera Pharmaceuticals have in Pakistan?
Medera Pharmaceuticals (Pvt) Ltd has 89 registered medicine presentations in Pakistan, sold under 59 brands and covering 47 generic medicines.
What are the main brands of Medera Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Olentine (Olanzapine + Fluoxetine), Avecare (Ceftriaxone), Azinal (Azithromycin), Respimed (Risperidone) and Viromed (Entecavir). This is not a sales ranking.
Which therapy areas does Medera Pharmaceuticals cover?
The most products are in Anti-infectives (56), CNS & mental health (16), Cardiovascular (7), Vitamins, minerals & nutrition (4) and Dermatology (3).
Where can I see Medera Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.